Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir - Concepedia

Concepedia

Publication | Open Access

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

DOI Full Paper Access

211

Citations

25

References

2016

Year

Christoph Sarrazin, Hadas Dvory‐Sobol, Evguenia S. Svarovskaia, Brian Doehle, Phillip S. Pang, Shu-Min Chuang, Julie Ma, Xiao Ding, Nezam H. Afdhal, Kris V. Kowdley,

Gastroenterology

Hcv Ns5aHealth SciencesViral HepatitisAntiviral TherapyHepatitisVirologyResistance-associated SubstitutionsResistance Mutation (Virology)Infection ControlAntiviral DrugMedicineClinical MicrobiologyEpidemiologyDrug Resistance

References

	Year	Citations

Page 1

Page 1